LXRX
LXRX
NASDAQ · Pharmaceuticals

Lexicon Pharmaceuticals Inc

$1.42
-0.06 (-4.05%)
As of Nov 7, 2:03 AM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 8 73%
Hold 3 27%
Sell 0 0%
Price Target
Analyst Price Target +1,165.5% upside
Low Target $15.16
Average Target $17.97
High Target $22.64
Current Price $1.42
Current
$1.42
Target
$17.97
$15.16 $17.97 avg $22.64
Scenario Analysis
Bear Case
$15.16
967.6%
Low target
Base Case
$17.97
+1,165.5%
Avg target
Bull Case
$22.64
+1,494.4%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$2.68
-47.0% from high
52-Week Low
$1.10
+29.1% from low
Target vs 52W High
$17.97
+570.5% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.06
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%